Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Idorsia Pharmaceuticals patents LGALS3 inhibitors

March 9, 2021

Collagen means well in pancreatic cancer

March 9, 2021

Chimerix opens enrollment in phase III study of dociparstat for AML

March 9, 2021

Incyte discloses CDK2/cyclin E inhibitors

March 8, 2021

BiSiChem identifies RIPK1 inhibitors

March 8, 2021

Taiho begins phase II study of TAS-117 in advanced solid tumors with germline PTEN mutations

March 8, 2021

Post-chemo bone marrow regeneration elucidated

March 8, 2021

CYH-33 demonstrates preliminary antitumor activity in PIK3CA-mutant tumors

March 5, 2021

New NTRK1 inhibitors discovered by Luoxin Pharmaceutical, Shandong Luoxin Pharmacy Group

March 5, 2021

New JAK-1/TYK2 inhibitors synthesized at the National Institute of Pharmaceutical R&D

March 5, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...